CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2011

Dec 14, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2011-12-14

Reporting Person: MCENANY PATRICK J (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-14	Common Stock, par value $0.001 per share	P	500	$1.055	Acquired	3168047	Direct
2011-12-14	Common Stock, par value $0.001 per share	P	9500	$1.06	Acquired	3177547	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	145922	Indirect

Footnotes

F1: Shares are owned by the Reporting Person's spouse